Publicaties
2024-03-04
Correction: van Veelen et al. First-in-Human Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: Rationale and Design of the DEBuT-LRP Study. J. Clin. Med. 2023, 12, 5807.
van Veelen A, Küçük IT, Fuentes FH, Kahsay Y, Garcia-Garcia HM, Delewi R, Beijk MAM, den Hartog AW, Grundeken MJ, Vis MM, Henriques JPS, Claessen BEPM.
Journal of clinical medicine
Edition: 2077-0383 | Pages: 1479
Lees artikel
2023-09-06
First-in-Human Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: Rationale and Design of the DEBuT-LRP Study.
van Veelen A, Küçük IT, Fuentes FH, Kahsay Y, Garcia-Garcia HM, Delewi R, Beijk MAM, den Hartog AW, Grundeken MJ, Vis MM, Henriques JPS, Claessen BEPM.
Journal of clinical medicine
Edition: 2077-0383 | Pages: 5807
Lees artikel
2023-06-09
Impact of the COVID-19 Outbreak on the Treatment of Myocardial Infarction Patients.
Grundeken MJ, Claessen BEPM.
Current treatment options in cardiovascular medicine
Edition: 1092-8464 | Pages: 1-11
Lees artikel
2023-02-07
Clinical Outcomes after Percutaneous Coronary Intervention for Cardiogenic Shock Secondary to Total Occlusive Unprotected Left Main Coronary Artery Lesion-Related Acute Myocardial Infarction.
Beijk MAM, Palacios-Rubio J, Grundeken MJD, Kalkman DN, De Winter RJ.
Journal of clinical medicine
Edition: 2077-0383 | Pages: 1311
Lees artikel
2021-12-21
A Narrative Review of Ultrathin-strut Drug-eluting Stents: The Thinner the Better?
Grundeken MJ, Beijk MA.
Heart international
Edition: 1826-1868 | Pages: 84-93
Lees artikel